Coronavac COVID-19 vaccine safe in children and adolescents and triggers antibodies

Two doses of CoronaVac are safe and provoke a strong antibody response among children and adolescents aged 3-17 years, according to a randomised controlled trial of 550 young people published in The Lancet Infectious Diseases journal.